In Pelton v Maytag, 2024 ONSC 3016 (“Pelton”) the Ontario Superior Court of Justice (the “Court”) ruled that the defendant…
Read More →
Contaminated eye drops present serious risks. Not only can they cause blindness and other serious medical conditions, but they have…
Read More →
In April, the U.S. Food and Drug Administration (FDA) released the results of its 2023 sampling assignment, testing for asbestos…
Read More →
Effective July 1, 2024, a revolutionary new law will protect Tennessee artists and musicians from unethical uses of Artificial Intelligence…
Read More →
In Ioengine, LLC v. Ingenico Inc. No. 2021-1227, 2021-1331, 2021-1332 (Fed. Cir. May 03, 2024), the case addresses the patentability/validity…
Read More →
Large language models (LLMs) have a well-known propensity to “hallucinate,” or provide false information in response to the user’s prompt—note…
Read More →
On May 2 2024, the Dutch data protection supervisory authority (the Dutch DPA) published guidance on the processing of personal…
Read More →
In Maxell, Ltd. v. Amperex Technology Limited, 2023-1194 (Fed. Cir. Mar. 6, 2024), the Federal Circuit reaffirms that a patent…
Read More →
Public spaces create community, but they also carry risks. While the expectation is that you will be safe and not…
Read More →
The 1980s British rock band, The Fixx, comes to mind when one reads the Food and Drug Administration’s recently issued…
Read More →